GUANGZHOU BIO-GENE TECHNOLOGY CO LTD

GUANGZHOU BIO-GENE TECHNOLOGY CO LTD (China) holds 1 active US FDA Type II Drug Master File. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “GUANGZHOU BIO-GENE TECHNOLOGY CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/guangzhou-bio-gene-technology-co-ltd

Overview

GUANGZHOU BIO-GENE TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering EXP EXOSOME.

API / Drug Master Files

GUANGZHOU BIO-GENE TECHNOLOGY CO LTD holds 1 active (1 total) FDA Type II Drug Master File. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • EXP EXOSOMEActive2024-11-29

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to GUANGZHOU BIO-GENE TECHNOLOGY CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this GUANGZHOU BIO-GENE TECHNOLOGY CO LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.